Baxter 2024 Revenue Based. Compared to $252 million net income last year. $20.1 billion), a global medtech leader,.
Last 3 years + 112.38 % / yr. Baxter international q4 2023 earnings call.
Earnings &Amp; Estimates Baxter International.
The medical instruments supplier reported $0.88 eps for the quarter, topping.
Overview Forecast Earnings Dividend Ownership.
Baxter international gets its buy rating from december reaffirmed, agreeing with today’s bullish consensus from sa analysts and wall street.
February 8, 2024 8:30 Am Est.
Images References :
Are Primarily Driven By Fitch’s Expectation That Leverage Will Remain Elevated Through.
Compared to $252 million net income last year.
Bax ), A Global Provider Of Infusion Therapies And Technologies, Has Received Fda 510 (K).
Gaap diluted earnings per share (eps) from continuing operations of $0.14 and adjusted.
Bax 0.19% Djia 0.50% S&Amp;P 500 0.01% Health Care/Life Sciences 0.43% Overview.
